EUVIMEDEUVIMED entdecken
Crossref

Dual-enzyme inhibitor screening against α-glucosidase and PTP1B by hollow fibers in tandem with ultrafiltration

Yan Shi, Renjie Fu, Jiayi Chen, Hui Lan, Boyang Yu, Jin Qi

Analytica Chimica Acta · 2025-05 · 1350 · 343833

DOI: 10.1016/j.aca.2025.343833 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytica Chimica Acta, 2025-05. Verfasst von Yan Shi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Complex Prescription of Traditional Chinese Medicine, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanji…. Hauptthemen laut MEDLINE: Protein Tyrosine Phosphatase, Non-Receptor Type 1, alpha-Glucosidases, Glycoside Hydrolase Inhibitors, Enzyme Inhibitors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 64 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Simultaneous inhibition of α-glucosidase (α-Glu) and protein tyrosine phosphatase 1B (PTP1B) offers a promising therapeutic strategy for type 2 diabetes (T2D). Despite the natural product potential in T2D management, existing screening methods predominantly target single enzymes, whereas multi-enzyme approaches are often costly and less practical. A simple, cost-effective method for identifying multi-target inhibitors is therefore urgently needed. RESULTS: A new dual-enzyme inhibitor screening system was developed to screen for α-Glu and PTP1B dual inhibitors in natural product extracts. This system, combining immobilized a hollow fiber and an ultrafiltration centrifugal device with mass spectrometry detection, enabled simultaneous screening of dual-enzyme inhibitors with a single sample injection. The drug first reacted with α-Glu in a hollow fiber, then passed through the fiber and reacted with free PTP1B, in a process mimicking the body's absorption and distribution processes more closely than traditional methods. Enzymatic reaction conditions were optimized with the known dual inhibitor (-)-epigallocatechin-3-O-gallate (EGCG). Subsequently, the method was used to screen potential inhibitors in white tea, Fructus Cnidii, and Citri Reticulatae Pericarpium extracts. For immobilized α-Glu, free α-Glu, and PTP1B, the calculated Michaelis-Menten constants (Km) were 5.75, 5.88 and 1.87 mM, respectively. After ligand fishing, molecular docking and inhibition assays were used to validate potent inhibitors. Finally, four catechin compounds were identified: EGCG, (-)-epicatechin gallate (ECG), catechin and (-)-epicatechin. Their IC50 values for α-Glu inhibition were 0.67, 0.79, 323.25, and 328.25 μM, respectively. For PTP1B inhibition, their IC50 values were 0.58, 0.84, 4.71, and 3.69 μM, respectively. These results demonstrated that the hollow fiber ultrafiltration system was a reliable method for screening dual-target inhibitors. SIGNIFICANCE AND NOVELTY: Our dual-enzyme reactor, the first system designed for dual-target screening, provided a simple, cost-effective, sensitive, reproducible, and selective approach for identifying dual-enzyme inhibitors. Its outstanding applicability to natural product extracts highlighted its potential for broad application in drug discovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Tyrosine Phosphatase, Non-Receptor Type 1alpha-GlucosidasesGlycoside Hydrolase InhibitorsEnzyme InhibitorsUltrafiltrationHumansDrug Evaluation, PreclinicalMolecular Docking Simulation

Stichwörter der Autor:innen

Dual-targetInhibitor screeningLigand fishingNatural productsType 2 diabetes

Substanzen

Protein Tyrosine Phosphatase, Non-Receptor Type 1alpha-GlucosidasesGlycoside Hydrolase InhibitorsPTPN1 protein, humanEnzyme Inhibitors

Autor:innen und Institutionen

  • Department of Complex Prescription of Traditional Chinese Medicine, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, 211198, PR China.
  • Department of Complex Prescription of Traditional Chinese Medicine, State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, 211198, PR China; Jiangsu Key Laboratory of TCM Evaluation and Tra…

Zitieren

APA

Shi, Y., Fu, R., Chen, J., Lan, H., Yu, B., & Qi, J. (2025). Dual-enzyme inhibitor screening against α-glucosidase and PTP1B by hollow fibers in tandem with ultrafiltration. Analytica Chimica Acta, 1350, 343833. https://doi.org/10.1016/j.aca.2025.343833

Vancouver

Shi Y, Fu R, Chen J, Lan H, Yu B, Qi J. Dual-enzyme inhibitor screening against α-glucosidase and PTP1B by hollow fibers in tandem with ultrafiltration. Analytica Chimica Acta. 2025;1350:343833. doi:10.1016/j.aca.2025.343833

BibTeX
@article{Shi2025,
  author = {Shi, Yan and Fu, Renjie and Chen, Jiayi and Lan, Hui and Yu, Boyang and Qi, Jin},
  title = {Dual-enzyme inhibitor screening against α-glucosidase and PTP1B by hollow fibers in tandem with ultrafiltration},
  journal = {Analytica Chimica Acta},
  year = {2025},
  volume = {1350},
  pages = {343833},
  doi = {10.1016/j.aca.2025.343833}
}
Kostenlos starten →